These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Cardiac involvement in systemic scleroderma: the clinical aspects and current study methods]. Bogdanov AP; Moiseev SV Ter Arkh; 1994; 66(5):87-91. PubMed ID: 7940353 [No Abstract] [Full Text] [Related]
50. [Results of 100-day treatment of generalized scleroderma with imuran]. Czernielewski A; Olszewska Z Przegl Dermatol; 1973; 60(6):761-7. PubMed ID: 4769960 [No Abstract] [Full Text] [Related]
51. Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study. Sfikakis PP; Panopoulos S; Mavrogeni S Rheumatology (Oxford); 2023 Sep; 62(9):e276-e277. PubMed ID: 36707992 [No Abstract] [Full Text] [Related]
52. Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: reply. Kato M; Ninagawa K; Atsumi T Rheumatology (Oxford); 2023 Sep; 62(9):e278-e279. PubMed ID: 36707999 [No Abstract] [Full Text] [Related]
54. Limited form of systemic sclerosis improved with enalapril. Martinez-Deben FS; Sesma P; Garrido JA Arch Intern Med; 1992 Dec; 152(12):2506-7. PubMed ID: 1456866 [No Abstract] [Full Text] [Related]
55. [Progressive scleroderma cured by the oral and parenteral administration of paramethyl-isopropyl-phenol (thymol)]. Buccellato G G Ital Dermatol Minerva Dermatol; 1965; 106(4):373-6. PubMed ID: 5899511 [No Abstract] [Full Text] [Related]
56. [Therapy of scleroderma with streptomycin in 1966-1967]. Klonowski S Pol Tyg Lek; 1969 Dec; 24(52):1999-2001. PubMed ID: 5370371 [No Abstract] [Full Text] [Related]
57. [The effect of procaine, griseofulvin and chloroquine on skin perfusion in progressive scleroderma]. Wiskemann A; Korff F Dermatol Wochenschr; 1967 Sep; 153(37):1033-7. PubMed ID: 5589729 [No Abstract] [Full Text] [Related]